SOP Guide for Pharma

Sterile Injectable Manufacturing: SOP for Container Closure Integrity Testing – V 2.0

Sterile Injectable Manufacturing: SOP for Container Closure Integrity Testing – V 2.0

Standard Operating Procedure for Container Closure Integrity Testing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/070/2025
Supersedes SOP/SIM/070/2022
Page No. Page 1 of 13
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

This SOP outlines the procedure for performing Container Closure Integrity Testing (CCIT) on sterile injectable pharmaceutical products to verify the integrity of packaging systems and ensure product sterility throughout its shelf life.

2. Scope

This procedure applies to all finished injectable products packaged in ampoules, vials, or prefilled syringes at the

sterile manufacturing facility.

3. Responsibilities

  • QC Analyst: Conducts CCIT and records the results.
  • QC Reviewer: Reviews data for compliance and correctness.
  • QA Officer: Verifies integrity test results prior to batch release.

4. Accountability

The Head of Quality Control is accountable for ensuring the integrity of the container closure system through validated CCIT methods.

5. Procedure

5.1 Sampling

  1. Collect samples from each batch as per sampling plan (refer Annexure-1: Sample Log).
  2. Include samples from the beginning, middle, and end of the filling process.

5.2 Test Methods

  1. Use any of the following validated techniques based on product and packaging type:
    • Vacuum Decay Method
    • Helium Leak Detection
    • High Voltage Leak Detection (HVLD)
    • Dye Ingress Test
  2. Ensure all equipment used is calibrated and validated before use (see Annexure-2: Equipment Calibration Log).

5.3 Execution of CCIT

  1. Inspect each sample using the chosen method according to the validated SOPs.
  2. For HVLD:
    • Connect the syringe/vial to the HVLD system.
    • Apply voltage and record any current leakage.
    • A value above set threshold indicates failure.
  3. For dye ingress:
    • Submerge samples in 0.1% methylene blue solution and apply vacuum.
    • Inspect for dye penetration after specified hold time.
  4. Document all observations in Annexure-3: CCIT Results Sheet.

5.4 Acceptance Criteria

  1. All samples must pass CCIT without leak detection, dye ingress, or voltage current beyond limit.
  2. If any sample fails, follow deviation and batch investigation procedures.

5.5 Handling Failures

  1. Isolate failed sample and inform QA.
  2. Initiate root cause investigation and evaluate impact on batch disposition.
  3. Record investigation in Annexure-4: CCIT Failure Report.

6. Abbreviations

  • CCIT: Container Closure Integrity Testing
  • HVLD: High Voltage Leak Detection
  • QA: Quality Assurance
  • QC: Quality Control
  • SOP: Standard Operating Procedure

7. Documents

  1. Sample Log – Annexure-1
  2. Equipment Calibration Log – Annexure-2
  3. CCIT Results Sheet – Annexure-3
  4. CCIT Failure Report – Annexure-4

8. References

  • USP <1207> Container Closure Integrity Testing
  • ICH Q8 – Pharmaceutical Development
  • WHO TRS 996 – Annex 6

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation QC Analyst QA Executive Head QA
Department Quality Control Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Sample Log

Date Product Batch No. Sampled By Remarks
17/06/2025 Diclofenac Injection DFC-0625-B Anil Sharma Start, mid, end samples

Annexure-2: Equipment Calibration Log

Equipment ID Type Calibration Date Calibrated By Remarks
HVLD-01 HV Leak Detector 01/06/2025 Rajesh Kumar Calibrated

Annexure-3: CCIT Results Sheet

Sample ID Method Result Tested By Remarks
DFC-0625-B-01 HVLD Pass Sunita Reddy

Annexure-4: CCIT Failure Report

Sample ID Failed Method Description Action Taken Reported By
DFC-0625-B-07 Dye Ingress Blue dye detected Sample quarantined Vinay Pawar

Revision History

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial issue New SOP QA Head
18/06/2025 2.0 Added HVLD protocol and updated annexures Annual Review QA Head
Exit mobile version